Pulmonx (LUNG) Operating Income Growth (1y) (2020 - 2025)
Pulmonx (LUNG) Operating Income Growth (1y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.14 Bn | 173.84 Bn | 6.27 Bn | -20.56% |
| 2 | Stryker | 128.35 Bn | 125.47 Bn | 3.81 Bn | 11.83% |
| 3 | Medtronic | 107.95 Bn | 98.73 Bn | 6.41 Bn | 30.43% |
| 4 | Boston Scientific | 68.16 Bn | 66.71 Bn | 3.61 Bn | 19.54% |
| 5 | Edwards Lifesciences | 47.67 Bn | 44.00 Bn | 1.29 Bn | 20.97% |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.17 Bn | 1.98 Bn | -18.12% |
| 7 | Dexcom | 28.45 Bn | 27.33 Bn | 750.30 Mn | 90.95% |
| 8 | Smith & Nephew | 26.83 Bn | 26.25 Bn | - | - |
| 9 | Koninklijke Philips | 25.36 Bn | 22.23 Bn | 2.07 Bn | 74.18% |
| 10 | Pulmonx | 50.56 Mn | -19.19 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1.87% |
| Jun 30, 2025 | 5.24% |
| Mar 31, 2025 | -0.19% |
| Dec 31, 2024 | 3.61% |
| Sep 30, 2024 | 6.90% |
| Jun 30, 2024 | 4.97% |
| Mar 31, 2024 | 11.37% |
| Dec 31, 2023 | 4.84% |
| Sep 30, 2023 | -8.94% |
| Jun 30, 2023 | -14.07% |
| Mar 31, 2023 | -4.67% |
| Dec 31, 2022 | -18.28% |
| Sep 30, 2022 | -42.71% |
| Jun 30, 2022 | -13.63% |
| Mar 31, 2022 | -25.40% |
| Dec 31, 2021 | -32.20% |
| Sep 30, 2021 | -82.54% |
| Jun 30, 2021 | -10.03% |
| Mar 31, 2021 | -104.69% |
| Dec 31, 2020 | -118.04% |